Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease

被引:60
作者
Chen, Jing [1 ,2 ,3 ]
Hamm, L. Lee [1 ,2 ]
Mohler, Emile R. [4 ]
Hudaihed, Alhakam [1 ]
Arora, Robin [1 ]
Chen, Chung-Shiuan [3 ]
Liu, Yanxi [3 ]
Browne, Grace [3 ]
Mills, Katherine T. [3 ]
Kleinpeter, Myra A. [1 ]
Simon, Eric E. [1 ]
Rifai, Nader [5 ]
Klag, Michael J. [6 ]
He, Jiang [1 ,2 ,3 ]
机构
[1] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70118 USA
[2] Tulane Univ, Sch Med, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70118 USA
[3] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA
[4] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[5] Harvard Univ, Sch Med, Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
来源
PLOS ONE | 2015年 / 10卷 / 07期
基金
美国国家卫生研究院;
关键词
FLOW-MEDIATED DILATION; INCIDENT CARDIOVASCULAR EVENTS; ASYMMETRIC DIMETHYLARGININE; BRACHIAL-ARTERY; RENAL-INSUFFICIENCY; DEATH; INFLAMMATION; DIALYSIS; VASODILATATION; PROGRESSION;
D O I
10.1371/journal.pone.0132047
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The interrelationship of multiple endothelial biomarkers and chronic kidney disease (CKD) has not been well studied. We measured asymmetric dimethylarginine (ADMA), L-arginine, soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), von Willebrand factor (vWF), flow-mediated dilation (FMD), and nitroglycerin-induced dilation (NID) in 201 patients with CKD and 201 community-based controls without CKD. Multivariable analyses were used to examine the interrelationship of endothelial biomarkers with CKD. The multivariable-adjusted medians (interquartile ranges) were 0.54 (0.40, 0.75) in patients with CKD vs. 0.25 (0.22, 0.27) mu mol/L in controls without CKD (p<0.0001 for group difference) for ADMA; 67.0 (49.6, 86.7) vs. 31.0 (27.7, 34.2) mu mol/L (p<0.0001) for L-arginine; 230.0 (171.6, 278.6) vs. 223.9 (178.0, 270.6) ng/mL (p=0.55) for sICAM-1; 981.7 (782.6, 1216.8) vs. 633.2 (507.8, 764.3) ng/mL (p<0.0001) for sVCAM-1; 47.9 (35.0, 62.5) vs. 37.0 (28.9, 48.0) ng/mL (p=0.01) for sE-selectin; 1320 (1044, 1664) vs. 1083 (756, 1359) mU/mL (p=0.008) for vWF; 5.74 (3.29, 8.72) vs. 8.80 (6.50, 11.39)% (p=0.01) for FMD; and 15.2 (13.5, 16.9) vs. 19.1 (17.2, 21.0)% (p=0.0002) for NID, respectively. In addition, the severity of CKD was positively associated with ADMA, L-arginine, sVCAM-1, sE-selectin, and vWF and inversely associated with FMD and NID. Furthermore, FMD and NID were significantly and inversely correlated with ADMA, L-arginine, sVCAM-1, sE-selectin, and vWF. In conclusion, these data indicate that multiple dysfunctions of the endothelium were present among patients with CKD. Interventional studies are warranted to test the effects of treatment of endothelial dysfunction on CKD.
引用
收藏
页数:10
相关论文
共 34 条
[1]   Inflammation, Hemostasis, and the Risk of Kidney Function Decline in the Atherosclerosis Risk in Communities (ARIC) Study [J].
Bash, Lori D. ;
Erlinger, Thomas P. ;
Coresh, Josef ;
Marsh-Manzi, Jane ;
Folsom, Aaron R. ;
Astor, Brad C. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) :596-605
[2]   Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community [J].
Boeger, Rainer H. ;
Sullivan, Lisa M. ;
Schwedhelm, Edzard ;
Wang, Thomas J. ;
Maas, Renke ;
Benjamin, Emelia J. ;
Schulze, Friedrich ;
Xanthakis, Vanessa ;
Benndorf, Ralf A. ;
Vasan, Ramachandran S. .
CIRCULATION, 2009, 119 (12) :1592-U65
[3]   Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients [J].
Bonomini, M ;
Reale, M ;
Santarelli, P ;
Stuard, S ;
Settefrati, N ;
Albertazzi, A .
NEPHRON, 1998, 79 (04) :399-407
[4]   Role of L-arginine in the pathogenesis and treatment of renal disease [J].
Cherla, G ;
Jaimes, EA .
JOURNAL OF NUTRITION, 2004, 134 (10) :2801S-2806S
[5]   Endothelial function and dysfunction - Testing and clinical relevance [J].
Deanfield, John E. ;
Halcox, Julian P. ;
Rabelink, Ton J. .
CIRCULATION, 2007, 115 (10) :1285-1295
[6]   Chronic kidney disease: the global challenge [J].
El Nahas, AM ;
Bello, AK .
LANCET, 2005, 365 (9456) :331-340
[7]   Asymmetric dimethylarginine and progression of chronic kidney disease:: The mild to moderate kidney disease study [J].
Fliser, D ;
Kronenberg, F ;
Kielstein, JT ;
Morath, C ;
Bode-Böger, SM ;
Haller, H ;
Ritz, E .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (08) :2456-2461
[8]   The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda [J].
Fliser, Danilo ;
Wiecek, Andrzej ;
Suleymanlar, Gultekin ;
Ortiz, Alberto ;
Massy, Ziad ;
Lindholm, Bengt ;
Martinez-Castelao, Alberto ;
Agarwal, Rajiv ;
Jager, Kitty J. ;
Dekker, Friedo W. ;
Blankestijn, Peter J. ;
Goldsmith, David ;
Covic, Adrian ;
London, Gerard ;
Zoccali, Carmine .
KIDNEY INTERNATIONAL SUPPLEMENTS, 2011, 1 (01) :6-9
[9]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305
[10]   Is Flow-Mediated Dilation Nitric Oxide Mediated? A Meta-Analysis [J].
Green, Daniel J. ;
Dawson, Ellen A. ;
Groenewoud, Hans M. M. ;
Jones, Helen ;
Thijssen, Dick H. J. .
HYPERTENSION, 2014, 63 (02) :376-382